Small animal imaging includes devices and reagents that are used for imaging rats and mice for the purpose of drug development and the study of gene expression. Small animal imaging devices are similar to devices used for diagnostic purposes for humans, except that the animal imaging devices are smaller in size and are thus referred to as micro devices. Animal imaging devices market are termed as micro-MRI, micro-SPECT, and others, and are used to analyze the anatomical, molecular, and functional aspects of the animal to understand the activity of pharmaceutical compounds in pre-clinical phase or the phase 1 stage. These visualization and analysis help in supporting the studies and evaluating the API’s activity, its safety, and toxicity. Small animal imaging is a non-invasive technique and therefore longitudinal studies are possible with accurate and detailed analysis.
Browse Full Global Small Animal Imaging Market Report with http://www.mrrse.com/small-animal-imaging
Rise in Demand for Pre-clinical CROs in Asia Pacific Boosts Small Animal Imaging Market
The small animal imaging market has received huge research funding, which has led to several technological advancements, thus leading to an exponential growth of the market. The growing installation of multimodal and optical imaging devices across the globe is one of the primary growth drivers for the small animal imaging market. The growth of the market can also be attributed to a growing demand for preclinical CROs in Asia Pacific and other developing countries of the world, boosting the market over the last decade.
The small animal imaging market is restrained by high development costs which limits the adoption of small animal imaging. Moreover, restricted access to nuclear imaging reagents is also a challenge that the market faces. However, the small animal imaging market is expected to continue along the lines of progress due to frequent purchases and a growing number of reagent manufacturers. Increased focus by companies on improvising on MRI-based multimodal imaging devices such as PET is likely to open the gates of new opportunities for the small animal imaging market in the period from 2014 to 2020.
Multimodal and Optical Imaging Segments Exhibits Fastest Growth
The global small animal imaging market is segmented on the basis of application, reagent, and device. By device, the market is segmented into micro-MRI imaging, micro-CT imaging, micro-PET/SPECT imaging, optical imaging, multimodal imaging, micro-PAT imaging, and micro-ultrasound imaging. Of these, the micro-MRI and micro-CT devices have established themselves well whereas the multimodal imaging and optical imaging markets are the fastest growing segments in the global small animal imaging market.
On the basis of reagents, the small animal imaging market is segmented into CT contrast reagents, MRI contrast reagents, nuclear contrast reagents, optical imaging contrast reagents, and ultrasound contrast reagents. Out of these the optical imaging reagents segment is the fastest growing, owing its fast growth to an increasing number of studies on gene expression.
Asia Pacific to be Fastest Growing Region Due to Increased Funding for Pre-clinical Research
Geographically the market for small animal imaging is segmented into Asia Pacific, Europe, North America, and the Rest of the World. While North America is dominant in the market, Asia Pacific is expected to be the fastest growing market along with RoW. The growth in the Asia Pacific region is largely due to a growing number of CROs and the increasing industry-based funding for conducting pharmaceutical based pre-clinical research.
Companies dominant in the market are: Aspect Imaging, Targeson, Inc., Bruker Corporation, TriFoil Imaging, Inc., Miltenyi Biotec GmbH, LI-COR Biosciences, Inc., Perkin Elmer, Inc., Siemens AG, Promega Corporation, SCANCO Medical AG and Agilent Technologies, Inc.